# FDA Inspection 1301896 - Nexus Pharmaceuticals, LLC - June 04, 2026

Source: https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/50e8e103-ce27-4d4c-aafe-99c6b6c73b6f
Source feed: FDA_Inspections

> FDA Inspection 1301896 for Nexus Pharmaceuticals, LLC on June 04, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1301896
- Company Name: Nexus Pharmaceuticals, LLC
- Inspection Date: 2026-06-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Chicago District Office

## Related Documents

- [FDA Inspection 1224257 - 2023-11-07](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/a46209ec-71b6-4f0f-9768-09461ae4c6c0)
- [FDA Inspection 1171206 - 2022-05-25](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/d820ab6f-59c0-4bda-89aa-27937437a5f9)
- [FDA Inspection 976279 - 2016-06-29](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/e3895940-f539-423b-9d7e-f21274a06b35)
- [FDA Inspection 903661 - 2014-11-05](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/32cc3842-5652-47d9-ae6e-69f963728a59)
- [FDA Inspection 871664 - 2014-03-28](https://www.keypedia.com/records/fda_inspections/nexus-pharmaceuticals-llc/a9f75950-966b-48b2-84d8-3c82a857af61)

Company: https://www.keypedia.com/companies/nexus-pharmaceuticals-llc/9f6c2dd9-2ee0-4492-bcaf-992ff47330cf

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669